IDERA PHARMACEUTICALS INC's ticker is IDRA and the CUSIP is 45168K405. A total of 42 filers reported holding IDERA PHARMACEUTICALS INC in Q3 2020. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2022 | $228,000 | -20.6% | 457,100 | -9.7% | 0.00% | 0.0% |
| Q4 2021 | $287,000 | -29.7% | 506,381 | +27.6% | 0.00% | -50.0% |
| Q3 2021 | $408,000 | -54.0% | 396,919 | -46.3% | 0.00% | -33.3% |
| Q2 2021 | $886,000 | +219.9% | 738,620 | +246.9% | 0.00% | +200.0% |
| Q1 2021 | $277,000 | +307.4% | 212,938 | +460.9% | 0.00% | – |
| Q2 2020 | $68,000 | -30.6% | 37,962 | -48.6% | 0.00% | -100.0% |
| Q1 2020 | $98,000 | -58.3% | 73,798 | -42.8% | 0.00% | 0.0% |
| Q4 2019 | $235,000 | -49.1% | 128,927 | -19.4% | 0.00% | -50.0% |
| Q3 2019 | $462,000 | +5.0% | 159,981 | -3.1% | 0.00% | 0.0% |
| Q2 2019 | $440,000 | +289.4% | 165,044 | +273.5% | 0.00% | – |
| Q1 2019 | $113,000 | +242.4% | 44,183 | +1110.2% | 0.00% | – |
| Q3 2018 | $33,000 | – | 3,651 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ABG Innovation Capital Partners III GP Ltd | 56,250 | $206,000 | 0.12% |
| Baker Brothers Advisors | 4,608,786 | $16,914,000 | 0.06% |
| Artal Group S.A. | 500,000 | $1,835,000 | 0.04% |
| HOLLENCREST CAPITAL MANAGEMENT | 90,000 | $331,000 | 0.04% |
| Spotlight Asset Group, Inc. | 21,500 | $79,000 | 0.03% |
| DCF Advisers, LLC | 18,755 | $69,000 | 0.03% |
| 683 Capital Management, LLC | 88,470 | $325,000 | 0.02% |
| Palo Alto Investors LP | 77,044 | $283,000 | 0.02% |
| Alpine Global Management, LLC | 13,966 | $51,000 | 0.01% |
| TCI Wealth Advisors, Inc. | 4,000 | $15,000 | 0.01% |